Showing results 1 to 20 of 94
next >
| Issue Date | Title | Author(s) |
| 2021-02-04 | Activation of TWEAK/Fn14 signaling suppresses TRAFs/NF-κB pathway in the pathogenesis of cancer | Gupta, G; Kazmi, I; Al-Abbasi, FA; Singh, Y; S, R; Rani, S; Mishra, A; Prasher, P; Jha, NK; Thangavelu, L; Dureja, H; Singh, SK; Bhatt, S; Chellappan, DK; Dua, K |
| 2022-01-01 | Advanced drug delivery system in the treatment of hyperglycemia and hypoglycemia | Arora, V; Kabra, A; Sharma, RB; Dureja, H; Dua, K |
| 2020-11 | Advanced drug delivery systems can assist in targeting coronavirus disease (COVID-19): A hypothesis | Mehta, M; Prasher, P; Sharma, M; Shastri, MD; Khurana, N; Vyas, M; Dureja, H; Gupta, G; Anand, K; Satija, S; Chellappan, DK; Dua, K |
| 2022-01-01 | Advanced drug delivery systems for targeting obesity | Gulati, N; Dua, K; Dureja, H |
| 2022-01-01 | Advanced drug delivery systems targeting metabolic disorders: erythropoietic protoporphyria | Verma, N; Thapa, K; Kanojia, N; Dureja, H; Dua, K |
| - | Advances in pulmonary drug delivery targeting microbial biofilms in respiratory diseases | Sharma, A; Kumar, D; Dahiya, K; Hawthorne, S; Jha, SK; Jha, NK; Nand, P; Girgis, S; Raj, S; Srivastava, R; Goswami, VK; Gregoriou, Y; El-Zahaby, SA; Ojha, S; Dureja, H; Gupta, G; Singh, S; Chellappan, DK; Dua, K |
| 2020-01 | Albumin Nano-Encapsulation of Piceatannol Enhances Its Anticancer Potential in Colon Cancer Via Downregulation of Nuclear p65 and HIF-1α. | Aljabali, AAA; Bakshi, HA; Hakkim, FL; Haggag, YA; Al-Batanyeh, KM; Al Zoubi, MS; Al-Trad, B; Nasef, MM; Satija, S; Mehta, M; Pabreja, K; Mishra, V; Khan, M; Abobaker, S; Azzouz, IM; Dureja, H; Pabari, RM; Dardouri, AAK; Kesharwani, P; Gupta, G; Dhar Shukla, S; Prasher, P; Charbe, NB; Negi, P; Kapoor, DN; Chellappan, DK; Webba da Silva, M; Thompson, P; Dua, K; McCarron, P; Tambuwala, MM |
| 2021-02-24 | An overview of vaccine development for COVID-19 | Shahcheraghi, SH; Ayatollahi, J; Aljabali, AA; Shastri, MD; Shukla, SD; Chellappan, DK; Jha, NK; Anand, K; Katari, NK; Mehta, M; Satija, S; Dureja, H; Mishra, V; Almutary, AG; Alnuqaydan, AM; Charbe, N; Prasher, P; Gupta, G; Dua, K; Lotfi, M; Bakshi, HA; Tambuwala, MM |
| 2020-11-29 | Anti-inflammatory and anticancer activities of Naringenin-loaded liquid crystalline nanoparticles in vitro. | Wadhwa, R; Paudel, KR; Chin, LH; Hon, CM; Madheswaran, T; Gupta, G; Panneerselvam, J; Lakshmi, T; Singh, SK; Gulati, M; Dureja, H; Hsu, A; Mehta, M; Anand, K; Devkota, HP; Chellian, J; Chellappan, DK; Hansbro, PM; Dua, K |
| 2020-10-30 | Antiproliferative effects of boswellic acids-loaded chitosan nanoparticles on human lung cancer cell line A549. | Solanki, N; Mehta, M; Chellappan, DK; Gupta, G; Hansbro, NG; Tambuwala, MM; Aa Aljabali, A; Paudel, KR; Liu, G; Satija, S; Hansbro, PM; Dua, K; Dureja, H |
| 2022-01-28 | Biological databases and tools for neurological disorders. | Usman, MB; Ojha, S; Jha, SK; Chellappan, DK; Gupta, G; Singh, SK; Dua, K; Roychoudhury, S; Kumar, N; Khan, FA; Dureja, H; Upadhye, V; Zacconi, F; Prasanna, P; Kesari, KK; Ashraf, GM; Alexiou, A; Jha, NK |
| 2022-06-13 | Biomedical applications of polymeric micelles in the treatment of diabetes mellitus: Current success and future approaches. | Kaur, J; Gulati, M; Zacconi, F; Dureja, H; Loebenberg, R; Ansari, MS; AlOmeir, O; Alam, A; Chellappan, DK; Gupta, G; Jha, NK; Pinto, TDJA; Morris, A; Choonara, YE; Adams, J; Dua, K; Singh, SK |
| 2021-06-23 | Biosynthetic exosome nanoparticles isolation, characterization, and their diagnostic and therapeutic applications | Anand, K; Chandrasekaran, B; Gupta, G; Dureja, H; Singh, SK; Gulati, M; Chellappan, DK; Balasubramanian, B; Femeela, I; Armugam, VA; Dua, K |
| 2021-07-01 | Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19 | Jeyaraman, M; Muthu, S; Bapat, A; Jain, R; ES, S; Gulati, A; Channaiah Anudeep, T; Dilip, SJ; Jha, NK; Kumar, D; Kesari, KK; Ojha, S; Dholpuria, S; Gupta, G; Dureja, H; Chellappan, DK; Singh, SK; Dua, K; Jha, SK |
| 2021-03-09 | Calcium sensing receptor hyperactivation through viral envelop protein E of SARS CoV2: A novel target for cardio‐renal damage in COVID‐19 infection | Singh, Y; Ali, H; Alharbi, KS; Almalki, WH; Kazmi, I; Al‐Abbasi, FA; Anand, K; Dureja, H; Singh, SK; Thangavelu, L; Chellappan, DK; Dua, K; Gupta, G |
| - | Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update | Mehta, M; Dhanjal, DS; Paudel, KR; Singh, B; Gupta, G; Rajeshkumar, S; Thangavelu, L; Tambuwala, MM; Bakshi, HA; Chellappan, DK; Pandey, P; Dureja, H; Charbe, NB; Singh, SK; Shukla, SD; Nammi, S; Aljabali, AA; Wich, PR; Hansbro, PM; Satija, S; Dua, K |
| 2019-12-01 | Central composite designed formulation, characterization and in vitro cytotoxic effect of erlotinib loaded chitosan nanoparticulate system | Pandey, P; Chellappan, DK; Tambuwala, MM; Bakshi, HA; Dua, K; Dureja, H |
| 2021-01-01 | Chapter 30 Biosynthetic exosome nanoparticles isolation, characterization, and their diagnostic and therapeutic applications | Anand, K; Chandrasekaran, B; Gupta, G; Dureja, H; Singh, SK; Gulati, M; Chellappan, DK; Balasubramanian, B; Femeela, I; Arumugam, VA; Dua, K |
| 2022 | Chemical Moieties as Advanced Therapeutics for Targeting Respiratory Disorders | Prasher, P; Sharma, M; Kapoor, DN; Negi, P; Gupta, G; Zacconi, FC; Tambuwala, MM; Mehta, M; Satija, S; Dureja, H; Chellappan, DK; Dua, K |
| 2023-05 | Chitosan based sorafenib tosylate loaded magnetic nanoparticles: Formulation and in-vitro characterization | Dahiya, M; Awasthi, R; Yadav, JP; Sharma, S; Dua, K; Dureja, H |
